Kestra Medical Technologies reported revenue of $30.97M and net income of -$44.09M for the quarter ended Jul 2026, up 59.9% year over year. This income statement covers 11 quarters of results from Jan 2024 through Jul 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 | Jul2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||
| Revenue | 8.28M | 10.05M | 12.78M | 14.71M | 15.09M | 17.23M | 19.37M | 22.57M | 24.55M | 28.64M | 30.97M |
| Cost of RevenueCost of Rev | 7.40M | 8.66M | 8.58M | 8.88M | 8.54M | 9.60M | 10.52M | 11.14M | 11.65M | 12.96M | 13.47M |
| Gross Profit | 0.88M | 1.40M | 4.20M | 5.83M | 6.55M | 7.63M | 8.85M | 11.42M | 12.91M | 15.68M | 17.50M |
| Operating items | |||||||||||
| Research & DevelopmentR&D | 3.73M | 3.82M | 3.40M | 3.51M | 3.35M | 5.39M | 4.00M | 4.88M | 4.97M | 5.63M | 6.80M |
| Selling, General & AdministrativeSG&A | 17.09M | 17.93M | 19.23M | 21.45M | 23.80M | 50.46M | 33.73M | 38.30M | 42.70M | 49.39M | 48.36M |
| Operating ExpensesOpex | 20.83M | 21.75M | 22.63M | 24.96M | 27.15M | 55.84M | 37.73M | 43.18M | 47.67M | 55.03M | 55.16M |
| Operating IncomeOp. Inc | -19.95M | -20.35M | -18.43M | -19.13M | -20.60M | -48.21M | -28.88M | -31.75M | -34.77M | -39.34M | -37.66M |
| EBIT | -19.95M | -20.35M | -18.43M | -19.13M | -20.60M | -48.21M | -28.88M | -31.75M | -34.77M | -39.34M | -37.66M |
| Non-operating items | |||||||||||
| Non Operating Interest Expenses | 1.65M | 1.94M | 1.87M | 2.32M | 1.78M | 1.76M | 1.91M | 1.90M | 1.89M | 1.84M | 1.93M |
| Interest & Investment IncomeInt & Inv Inc | 0.04M | 0.88M | 0.63M | 1.66M | 2.17M | 1.80M | 2.16M | 2.23M | 2.12M | ||
| Other Non Operating IncomeOther Non Op Inc. | -0.01M | -0.03M | -0.05M | -0.04M | 0.01M | -2.69M | 2.83M | -0.89M | 0.36M | 0.32M | -6.30M |
| Net income details | |||||||||||
| EBT | -21.61M | -22.31M | -20.32M | -20.61M | -21.74M | -51.01M | -25.79M | -32.75M | -34.13M | -38.64M | -44.04M |
| Tax ProvisionsTaxes | 0.01M | -0.03M | 0.01M | 0.01M | 0.02M | 0.10M | 0.03M | 0.03M | 0.04M | 0.19M | 0.05M |
| Profit After TaxPAT | -21.62M | -22.28M | -20.32M | -20.62M | -21.76M | -51.11M | -25.83M | -32.78M | -34.17M | -38.84M | -44.09M |
| Income from Non-Controlling InterestsInc. Minority | -0.44M | -0.25M | -0.25M | ||||||||
| Income from Continuing OperationsIncome (Continuing) | -21.62M | -22.28M | -20.32M | -20.62M | -21.76M | -51.11M | -25.83M | -32.78M | -34.17M | -38.84M | -44.09M |
| Consolidated Net IncomeConsol Net Inc. | -21.62M | -22.28M | -20.32M | -20.62M | -21.76M | -51.11M | -25.83M | -32.78M | -34.17M | -38.84M | -44.09M |
| Income towards Parent CompanyParent Net Inc | -21.62M | -22.28M | -19.88M | -20.37M | -21.51M | -52.05M | -25.83M | -32.78M | -34.17M | -38.84M | -44.09M |
| Preferred Dividend PaymentsPref Dividends | 1.81M | 1.99M | 2.38M | 3.32M | 3.32M | 3.29M | |||||
| Net Income towards Common StockholdersNet Income | -23.43M | -24.28M | -22.27M | -23.69M | -24.83M | -55.34M | -25.83M | -32.78M | -34.17M | -38.84M | -44.09M |
| Additional items | |||||||||||
| EPS (Basic) | -1.18 | -1.22 | -1.12 | -1.19 | -1.25 | -2.25 | -0.50 | -0.64 | -0.61 | -0.72 | -0.75 |
| EPS (Diluted) | -1.18 | -1.22 | -1.12 | -1.19 | -1.25 | -2.25 | -0.50 | -0.64 | -0.61 | -0.72 | -0.75 |
| Shares Outstanding | 19.89M | 19.89M | 19.89M | 19.89M | 19.89M | 24.58M | 51.30M | 51.38M | 55.85M | 54.18M | 58.57M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 19.89M | 19.89M | 19.89M | 19.89M | 19.89M | 24.58M | 51.30M | 51.38M | 55.85M | 54.18M | 58.57M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 19.89M | 19.91M | 19.91M | 19.91M | 19.89M | 24.58M | 51.35M | 51.45M | 58.35M | 58.38M | 59.56M |
| EBITDA | -16.58M | -16.85M | -16.06M | -17.27M | -18.71M | -46.38M | -26.85M | -29.38M | -32.78M | -37.02M | -34.99M |
| Interest ExpensesInt Expense | 1.65M | 1.94M | 1.87M | 2.32M | 1.78M | 1.76M | 1.91M | 1.90M | 1.89M | 1.84M | 1.93M |
Pull Kestra Medical Technologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=KMTS&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "KMTS", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=KMTS&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();